electroCore, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ECOR Nasdaq 3841 https://www.electrocore.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for electroCore, Inc.

electroCore Announces Fourth Quarter and Full Year 2018 Financial Results - Mar 27th, 2019 2:05 pm
electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27 - Mar 18th, 2019 2:05 pm
electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™ - Mar 14th, 2019 6:00 am
4 Stocks Join Ben Graham Net-Net Screener Friday - Mar 8th, 2019 3:08 pm
UPDATE - electroCore Appointments Multiple Industry Veterans to Key Management Positions - Mar 8th, 2019 1:23 pm
electroCore Appointments Multiple Industry Veterans to Key Management Positions - Mar 8th, 2019 6:00 am
electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark - Feb 26th, 2019 6:00 am
electroCore and HealthyWomen Announce Partnership on Patient Program to Increase Awareness of Non-Drug Migraine Therapies - Feb 19th, 2019 6:00 am
LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index - Feb 1st, 2019 9:30 am
electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference - Jan 28th, 2019 6:00 am
electroCore Announces Two New Studies and a Publication Supporting the Practical Utility of Non-invasive Vagus Nerve Stimulation in Adults - Jan 8th, 2019 6:00 am
gammaCore™ Now Available Through U.S. Federal Government’s Federal Supply Schedule (FSS) - Jan 2nd, 2019 6:00 am
Is electroCore, Inc.’s (NASDAQ:ECOR) Balance Sheet Strong Enough To Weather A Storm? - Dec 21st, 2018 8:36 am
electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults - Nov 28th, 2018 6:03 am
FDA Changes Will Reward Medical Device Innovation: Here’s What Investors Need to Know - Nov 28th, 2018 5:25 am
electroCore Expands Manufacturing Capabilities for gammaCore™ - Nov 27th, 2018 6:00 am
Market Trends Toward New Normal in Tandy Leather Factory, Boxlight, Willamette Valley Vineyards, electroCore, FAT Brands, and Village Super Market — Emerging Consolidated Expectations, Analyst Ratings - Nov 21st, 2018 5:50 am
electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference - Nov 20th, 2018 2:05 pm
electroCore, Inc. Announces Third Quarter Financial Results - Nov 13th, 2018 2:05 pm
NICE publishes advice on gammaCore for the treatment of cluster headache in the UK - Nov 9th, 2018 6:40 am